Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Return on Assets: 2013-2025

Historic Return on Assets for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to -0.44%.

  • Fortress Biotech's Return on Assets rose 43.00% to -0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.44%, marking a year-over-year increase of 43.00%. This contributed to the annual value of -0.78% for FY2024, which is 11.00% down from last year.
  • Fortress Biotech's Return on Assets amounted to -0.44% in Q3 2025, which was up 32.77% from -0.66% recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Return on Assets peaked at -0.28% during Q1 2021, and registered a low of -1.06% during Q3 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.79% (2023), whereas its average is -0.78%.
  • As far as peak fluctuations go, Fortress Biotech's Return on Assets slumped by 44bps in 2023, and later surged by 43bps in 2025.
  • Quarterly analysis of 5 years shows Fortress Biotech's Return on Assets stood at -0.46% in 2021, then decreased by 21bps to -0.67% in 2022, then declined by 25bps to -0.92% in 2023, then grew by 7bps to -0.86% in 2024, then surged by 43bps to -0.44% in 2025.
  • Its Return on Assets stands at -0.44% for Q3 2025, versus -0.66% for Q2 2025 and -0.63% for Q1 2025.